Sectoral Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.48M | Sell |
2,919
-796
| -21% | -$609K | 2.06% | 15 |
|
|
2025
Q4 | $2.87M | Sell |
3,715
-253
| -6% | -$172K | 2.3% | 11 |
|
|
2025
Q3 | $2.23M | Buy |
3,968
+1,195
| +43% | +$676K | 1.38% | 28 |
|
|
2025
Q2 | $1.46M | Hold |
2,773
| – | – | 0.96% | 39 |
|
|
2025
Q1 | $1.76M | Sell |
2,773
-627
| -18% | -$431K | 1.37% | 19 |
|
|
2024
Q4 | $2.42M | Hold |
3,400
| – | – | 1.62% | 15 |
|
|
2024
Q3 | $3.57M | Sell |
3,400
-2,640
| -44% | -$2.94M | 2.11% | 8 |
|
|
2024
Q2 | $6.35M | Sell |
6,040
-1,035
| -15% | -$1M | 2.58% | 9 |
|
|
2024
Q1 | $6.81M | Buy |
7,075
+3,240
| +84% | +$3.08M | 2.68% | 9 |
|
|
2023
Q4 | $3.37M | Buy |
3,835
+115
| +3% | +$94.7K | 1.45% | 22 |
|
|
2023
Q3 | $3.06M | Buy |
3,720
+524
| +16% | +$412K | 0.6% | 70 |
|
|
2023
Q2 | $2.3M | Buy |
3,196
+406
| +15% | +$313K | 0.38% | 80 |
|
|
2023
Q1 | $2.29M | Buy |
2,790
+80
| +3% | +$60.3K | 0.44% | 76 |
|
|
2022
Q4 | $1.96M | Sell |
2,710
-610
| -18% | -$450K | 0.38% | 80 |
|
|
2022
Q3 | $2.29M | Buy |
3,320
+110
| +3% | +$69.2K | 0.45% | 74 |
|
|
2022
Q2 | $1.9M | Buy |
3,210
+170
| +6% | +$111K | 0.38% | 82 |
|
|
2022
Q1 | $2.12M | Sell |
3,040
-370
| -11% | -$234K | 0.38% | 79 |
|
|
2021
Q4 | $2.15M | Sell |
3,410
-310
| -8% | -$191K | 0.32% | 80 |
|
|
2021
Q3 | $2.25M | Sell |
3,720
-500
| -12% | -$310K | 0.19% | 105 |
|
|
2021
Q2 | $2.36M | Sell |
4,220
-400
| -9% | -$203K | 0.19% | 101 |
|
|
2021
Q1 | $2.19M | Hold |
4,620
| – | – | 0.17% | 93 |
|
|
2020
Q4 | $2.23M | Sell |
4,620
-18,310
| -80% | -$9.88M | 0.16% | 79 |
|
|
2020
Q3 | $12.8M | Buy |
22,930
+4,892
| +27% | +$2.97M | 1.1% | 39 |
|
|
2020
Q2 | $11.2M | Buy |
18,038
+10,268
| +132% | +$5.83M | 1.03% | 44 |
|
|
2020
Q1 | $3.79M | Buy |
+7,770
| New | +$3.21M | 0.73% | 51 |
|
|
2018
Q4 | – | Sell |
-1,370
| Closed | -$554K | – | 127 |
|
|
2018
Q3 | $554K | Buy |
+1,370
| New | +$521K | 0.06% | 83 |
|
|
2018
Q1 | – | Sell |
-39,316
| Closed | -$14.8M | – | 77 |
|
|
2017
Q4 | $14.8M | Buy |
39,316
+6,399
| +19% | +$2.59M | 1.85% | 21 |
|
|
2017
Q3 | $14.7M | Sell |
32,917
-29,981
| -48% | -$14.3M | 1.9% | 26 |
|
|
2017
Q2 | $30.9M | Buy |
62,898
+57,203
| +1,004% | +$25M | 3.38% | 8 |
|
|
2017
Q1 | $2.21M | Buy |
+5,695
| New | +$2.11M | 0.26% | 50 |
|
|
2016
Q2 | – | Sell |
-232,770
| Closed | -$83.9M | – | 75 |
|
|
2016
Q1 | $83.9M | Sell |
232,770
-3,530
| -1% | -$1.45M | 4.06% | 6 |
|
|
2015
Q4 | $128M | Sell |
236,300
-7,800
| -3% | -$4.23M | 5.47% | 5 |
|
|
2015
Q3 | $114M | Buy |
244,100
+69,200
| +40% | +$37.2M | 5.2% | 4 |
|
|
2015
Q2 | $89.2M | Buy |
+174,900
| New | +$85.4M | 3.72% | 7 |
|
|
2015
Q1 | – | Sell |
-185,685
| Closed | -$76.2M | – | 80 |
|
|
2014
Q4 | $76.2M | Sell |
185,685
-42,115
| -18% | -$16.6M | 3.42% | 8 |
|
|
2014
Q3 | $82.1M | Sell |
227,800
-100
| -0% | -$33.5K | 3.46% | 9 |
|
|
2014
Q2 | $64.4M | Sell |
227,900
-79,500
| -26% | -$23.6M | 2.73% | 12 |
|
|
2014
Q1 | $92.3M | Buy |
307,400
+31,400
| +11% | +$9.67M | 3.8% | 5 |
|
|
2013
Q4 | $76M | Buy |
276,000
+101,000
| +58% | +$29M | 3.28% | 6 |
|
|
2013
Q3 | $54.8M | Sell |
175,000
-99,666
| -36% | -$26.2M | 2.63% | 15 |
|
|
2013
Q2 | $61.8M | Buy |
+274,666
| New | +$64M | 1.83% | 22 |
|
Other funds holding REGN
VCM
N
Sectoral Asset Management's REGN Position: Q1 2026 in Review
Sectoral Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 21% in Q1 2026, selling an estimated $609K and leaving 2,919 shares worth $2.48M. The position accounts for 2.06% of the portfolio, ranked #15.
Sectoral Asset Management first reported a position in REGN in Q2 2013 and has held it in 41 quarters since. The position peaked at $128M in Q4 2015. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Sectoral Asset Management held 2,919 shares of Regeneron Pharmaceuticals worth $2.48M as of Q1 2026.
- Sectoral Asset Management sold 796 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $609K.
- Regeneron Pharmaceuticals made up 2.06% of Sectoral Asset Management's portfolio in Q1 2026, its #15 holding.
- Sectoral Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 41 quarters since.
- Sectoral Asset Management's Regeneron Pharmaceuticals position peaked at $128M in Q4 2015.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Sectoral Asset Management's 13F filing for Q1 2026, filed 15 May 2026.